RGNX
REGENXBIO Inc.
NASDAQ · USHealthcareBiotechnology
$10.32+4.35%
Price as of Jul 20, 2026
RGNX capital
REGENXBIO Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 3.37x
- Net debt / equity
- 2.65x
- Debt / assets
- 0.21x
- Debt / EBITDA
- -0.31x
- Net debt / EBITDA
- -0.24x
Liquidity & coverage
- Current ratio
- 2.62x
- Quick ratio
- 2.62x
- Cash ratio
- 2.12x
- Interest coverage
- -5.69x
- EBITDA / interest
- -5.08x
- Working capital
- $115.4M
Cash & dividend
- FCF / debt
- -3.33x
- Cash flow / debt
- -3.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.